EKF Diagnostics Holdings's quarterly market cap
declined
from Dec. 2024 (£122.51 Mil) to Jun. 2025 (£120.36 Mil) and
declined
from Jun. 2025 (£120.36 Mil) to Dec. 2025 (£114.53 Mil).
EKF Diagnostics Holdings's annual market cap
declined
from Dec. 2023 (£143.61 Mil) to Dec. 2024 (£122.51 Mil) and
declined
from Dec. 2024 (£122.51 Mil) to Dec. 2025 (£114.53 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. EKF Diagnostics Holdings's Enterprise Value for Today is £102.09 Mil.
EKF Diagnostics Holdings (LSE:EKF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
EKF Diagnostics Holdings Market Cap Related Terms
EKF Diagnostics Holdings Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, EKF Diagnostics Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EKF Diagnostics Holdings Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, EKF Diagnostics Holdings's Market Cap distribution charts can be found below:
* The bar in red indicates where EKF Diagnostics Holdings's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
EKF Diagnostics Holdings's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EKF Diagnostics Holdings (LSE:EKF) has a Market Cap of £113.16 Mil as of Jul. 03, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on EKF Diagnostics Holdings and its competitors. According to the industry distribution chart, EKF Diagnostics Holdings ranks #406 out of 869 companies in the Medical Devices & Instruments industry, placing it in the top 46.7%.
Is EKF Diagnostics Holdings' Market Cap too high?
EKF Diagnostics Holdings' current Market Cap is £113.16 Mil. Based on the distribution chart, EKF Diagnostics Holdings ranks #406 out of 869 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, EKF Diagnostics Holdings has a GF Score™ of 52/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does EKF Diagnostics Holdings' Market Cap compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, EKF Diagnostics Holdings ranks #406 out of 869 companies for Market Cap. This puts EKF Diagnostics Holdings in the upper half of its industry. The industry median Market Cap is 119.28. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 119.28, based on 869 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on EKF Diagnostics Holdings and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 119.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EKF Diagnostics Holdings's current Market Cap is £113.16 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EKF Diagnostics Holdings stock overvalued right now?
Based on GuruFocus' analysis, EKF Diagnostics Holdings (LSE:EKF) is currently considered Fairly Valued. The stock's GF Value™ is £0.28, compared to a current price of £0.26 — trading 6.1% below its estimated fair value. The current Market Cap is £113.16 Mil. EKF Diagnostics Holdings' overall GF Score™ is 52/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For EKF Diagnostics Holdings (LSE:EKF), the current Market Cap is £113.16 Mil as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is EKF Diagnostics Holdings (LSE:EKF) Overvalued in 2026?
Based on GuruFocus' analysis, EKF Diagnostics Holdings stock appears to be undervalued.
The current stock price of £0.26 is trading 6.1% below its estimated GF Value™ of £0.28.
GuruFocus considers EKF Diagnostics Holdings to be Fairly Valued.
Key valuation signals for LSE:EKF:
Market Cap: £113.16 Mil
GF Value™: £0.28 vs. price of £0.26 (6.1% below fair value)
No single metric tells the full story. See the LSE:EKF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EKF Diagnostics Holdings PLC is engaged in development, manufacture and supply of products and services into the in-vitro diagnostic (IVD) market place. The Group has presence in the UK, USA, Germany, and Russia, and sells throughout the world including Europe, the Middle East, the Americas, Asia, and Africa. It derive their revenue from the manufacture and sale of medical diagnostic equipment and reagents. Other services include the servicing and distribution of third party company products under separate distribution agreements.
52GF Score
Get the complete analysis for LSE:EKF
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:EKF has been successfully added to your 
